High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research

Project description

Tumour bioprinting: the future of drug discovery

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drug
• engineering and technology › electrical engineering, electronic engineering, information engineering › electronic engineering › robotics
• medical and health sciences › clinical medicine › cancer

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

CELLINK AB

Address

Arvid Wallgrens Backe 20
413 46 Goteborg
Sweden

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 450 327,25